• Session I
  • Session II
  • Session III
  • Session IV
  • Session V

SESSION V: Ovarian Cancer III: Novel Therapies

  • Emerging options in antiangiogenic targeted therapy for ovarian cancer
    Andrew Clamp, MD, PhD
  • Targeted therapy for ovarian cancer: Beyond angiogenesis
    Stanley B. Kaye, MD

Download slide deck

This activity is supported by Morphotek and MSD.